Lead lipid nanoparticles as inhalable delivery vehicles for messenger RNA and CRISPR–Cas9 gene editors

The latest bioweapons delivery system from Moderna multibillionaire Robert Langer

Moderna multibillionaire Bob Langer, the “Coronavirus Common Denominator,” has invented a new biological weapons delivery system: “lead lipid nanoparticles” as “inhalable delivery vehicles for messenger RNA and CRISPR–Cas9 gene editors.”

Read more in MIT’s press release: “New nanoparticles can perform gene editing in the lungs.”

Langer is involved in Acorda, an inhalable pharmaceuticals company. For Acorda, he developed ARCUS:

ARCUS® is an innovative technology platform that transforms medicines into light, dry powders. These powders are designed to deliver high doses of medication through an inhalation device that is activated by a patient’s own breath.

The Bill & Melinda Gates Foundation is another ARCUS partner.

For more information on Robert Langer, read “Why Is Charles Koch Funding the COVID Origins Cover-Up? Koch's Relationship with Moderna’s Robert Langer Reveals His Role in the Plandemic.”